CTKB
NASD Cytek Biosciences, Inc.$5.58 ↓ -0.18 (-3.19%) Trading Down from the previous close of $5.76
- YTD change
- +10.42%
- vs 20-day SMA
- +9.43%
- vs 200-day SMA
- +21.31%
Price ranges
Price & Performance
+1.46 (+33.95%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 80.6% away from all-time highs of $28.70
- CTKB is up 10% since the beginning of the year
- CTKB is up 61% over the past 12 months
- CTKB is up 17% over the past 1 month
- 4% of all CTKB investors are betting against CTKB
CTKB reads neutral: price sits above both the 20- and 200-day averages, the 12-month move is +66.0%.
- Previous minute
- +$0.00
- Last hour
- -$0.29
- Last 5 days
- -2.34%
- vs 8-day SMA
- -0.54%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Cytek Biosciences, Inc. is a life sciences technology company, which engages in the provision of cell analysis tools by leveraging novel technical approaches. Its products include Cytek Aurora CS, Cytek Aurora, Cytek Northern Lights, and Cytek NL-CLC. The company was founded by Wenbin Jiang and Ming Yan in 1992 and is headquartered in Fremont, CA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.